Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Nuvalent (NUVL)

Nuvalent Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NUVL
DateTimeSourceHeadlineSymbolCompany
21/06/202221:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
21/06/202211:30PR Newswire (US)Nuvalent Announces Clinical Progress on Parallel Lead Programs NVL-520 and NVL-655 for NSCLC and Solid Tumor CancersNASDAQ:NUVLNuvalent Inc
17/06/202222:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
17/06/202221:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
17/06/202221:17Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
17/06/202221:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
02/06/202211:38PR Newswire (US)Nuvalent to Present at the 2022 Jefferies Healthcare ConferenceNASDAQ:NUVLNuvalent Inc
19/05/202221:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
12/05/202211:53Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:NUVLNuvalent Inc
12/05/202211:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUVLNuvalent Inc
12/05/202211:30PR Newswire (US)Nuvalent Highlights Pipeline and Business Progress and Reports First Quarter 2022 Financial ResultsNASDAQ:NUVLNuvalent Inc
29/04/202221:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:NUVLNuvalent Inc
08/04/202218:15PR Newswire (US)Nuvalent Presents New Data Demonstrating Expanded Preclinical Activity with ROS1-Selective Inhibitor NVL-520 and ALK-Selective Inhibitor NVL-655 at AACR Annual Meeting 2022NASDAQ:NUVLNuvalent Inc
07/04/202211:30PR Newswire (US)Nuvalent to Participate in the 2022 Canaccord Genuity Horizons in Oncology Virtual ConferenceNASDAQ:NUVLNuvalent Inc
31/03/202212:08Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:NUVLNuvalent Inc
31/03/202211:30PR Newswire (US)Nuvalent Appoints Anna Protopapas as Chair of Board of DirectorsNASDAQ:NUVLNuvalent Inc
29/03/202212:32Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:NUVLNuvalent Inc
29/03/202212:22Edgar (US Regulatory)Annual Report (10-k)NASDAQ:NUVLNuvalent Inc
29/03/202211:58Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUVLNuvalent Inc
29/03/202211:30PR Newswire (US)Nuvalent Reports Pipeline and Business Progress and Fourth Quarter and Full Year 2021 Financial ResultsNASDAQ:NUVLNuvalent Inc
08/03/202222:38PR Newswire (US)Nuvalent to Present New Preclinical Data on ROS1-Selective Inhibitor NVL-520 and ALK-Selective Inhibitor NVL-655 at AACR Annual Meeting 2022NASDAQ:NUVLNuvalent Inc
02/03/202211:30PR Newswire (US)Nuvalent to Participate in the Cowen 42nd Annual Healthcare ConferenceNASDAQ:NUVLNuvalent Inc
11/02/202221:19Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:NUVLNuvalent Inc
09/02/202214:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:NUVLNuvalent Inc
03/02/202211:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:NUVLNuvalent Inc
03/02/202211:30PR Newswire (US)Nuvalent Appoints Emily Drabant Conley, PhD, to Board of DirectorsNASDAQ:NUVLNuvalent Inc
07/01/202211:30PR Newswire (US)Nuvalent Announces First Patient Dosed in ARROS-1 Phase 1/2 Clinical Trial of NVL-520, its Novel ROS1-selective InhibitorNASDAQ:NUVLNuvalent Inc
05/01/202222:25Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
05/01/202222:22Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
05/01/202222:20Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:NUVLNuvalent Inc
 Showing the most relevant articles for your search:NASDAQ:NUVL

Your Recent History

Delayed Upgrade Clock